CTGL Stock Overview
Operates as a plant-based wellness and pharma solutions company in Israel.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Citrine Global Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.008 |
| 52 Week High | US$0.042 |
| 52 Week Low | US$0.005 |
| Beta | 0.35 |
| 11 Month Change | -20.00% |
| 3 Month Change | -20.00% |
| 1 Year Change | -80.00% |
| 33 Year Change | -70.91% |
| 5 Year Change | -95.29% |
| Change since IPO | -98.98% |
Recent News & Updates
Recent updates
Shareholder Returns
| CTGL | US Personal Products | US Market | |
|---|---|---|---|
| 7D | -46.7% | 1.2% | 0.4% |
| 1Y | -80.0% | -28.7% | 22.9% |
Return vs Industry: CTGL underperformed the US Personal Products industry which returned -29.4% over the past year.
Return vs Market: CTGL underperformed the US Market which returned 23.3% over the past year.
Price Volatility
| CTGL volatility | |
|---|---|
| CTGL Average Weekly Movement | n/a |
| Personal Products Industry Average Movement | 8.7% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in US Market | 15.5% |
| 10% least volatile stocks in US Market | 2.9% |
Stable Share Price: CTGL's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine CTGL's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | 18 | Ora Soffer | www.citrine-global.com |
Citrine Global Corp. operates as a plant-based wellness and pharma solutions company in Israel. The company focuses on developing plant-based products to enhance quality of life, and complementary solutions for balancing side effects caused by using medicines, cannabis, treatments, or an unbalanced lifestyle. It offers SmokLy sprays for cannabis users and tobacco smokers; and DryLess sprays for adult population with constant dry mouth, and other cancer treatment patients with constant dry mouth as part of their cancer treatment regimen.
Citrine Global Corp. Fundamentals Summary
| CTGL fundamental statistics | |
|---|---|
| Market cap | US$12.00m |
| Earnings (TTM) | -US$2.38m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-3.5x
P/E RatioIs CTGL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CTGL income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$2.38m |
| Earnings | -US$2.38m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0023 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | -83.4% |
How did CTGL perform over the long term?
See historical performance and comparison